Abstract
Background/Aim—The suggestion that estimation of faecal elastase 1 is a valuable new tubeless pancreatic function test was evaluated by comparing it with faecal chymotrypsin estimation in patients categorised according to grades of exocrine pancreatic insufficiency (EPI) based on the gold standard tests, the secretin-pancreozymin test (SPT) and faecal fat analysis. Methods—In 64 patients in whom EPI was suspected, the following tests were performed: SPT, faecal fat analysis, faecal chymotrypsin estimation, faecal elastase 1 estimation. EPI was graded according to the results of the SPT and faecal fat analysis as absent, mild, moderate, or severe. The upper limit of normal for faecal elastase 1 was taken as 200 µg/g, and for faecal chymotrypsin 3 U/g stool. Levels between 3 and 6 U/g stool for faecal chymotrypsin are usually considered to be suspicious for EPI. In this study, both 3 and 6 U/g stool were evaluated as the upper limit of normal. Results—Exocrine pancreatic function was normal in 34 patients, of whom 94, 91, and 79% had normal faecal elastase 1 and faecal chymotrypsin levels (<3 U/g and <6 U/g) respectively. Thirty patients had EPI, of whom 53, 37, and 57% had abnormal faecal enzyme levels (differences not significant). When EPI was graded as mild, moderate, or severe, 63% of patients had mild to moderate EPI, and 37% had severe EPI. In the latter group, between 73 and 91% of patients had abnormal faecal enzymes. In the group with mild to moderate EPI, abnormal test results were obtained for both faecal enzymes in less than 50% of the patients (differences not significant). Some 40% of the patients had pancreatic calcifications. There were no significant differences for either faecal enzyme between the two groups with and without pancreatic calcifications. In 62% of the patients who underwent an endoscopic retrograde cholangiopancreatography (ERCP), abnormal duct changes were found. Again, there were no significant differences for either faecal enzyme between the two groups with abnormal and normal ERCP. Conclusion—Estimation of faecal elastase 1 is not distinctly superior to the traditional faecal chymotrypsin estimation. The former is particularly helpful only in detecting severe EPI, but not the mild to moderate form, which poses the more frequent and difficult clinical problem and does not correlate significantly with the severe morphological changes seen in chronic pancreatitis.
Keywords: faecal elastase 1; faecal chymotrypsin; secretin-pancreozymin test; faecal fat analysis; exocrine pancreatic insufficiency; diagnosis
Full Text
The Full Text of this article is available as a PDF (94.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amann S. T., Bishop M., Curington C., Toskes P. P. Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis. Pancreas. 1996 Oct;13(3):226–230. doi: 10.1097/00006676-199610000-00002. [DOI] [PubMed] [Google Scholar]
- CREUTZFELDT W. FUNKTIONSDIAGNOSTIK BEI ERKRANKUNGEN DES EXOKRINEN PANKREAS. Verh Dtsch Ges Inn Med. 1964;70:781–801. [PubMed] [Google Scholar]
- Domínguez-Muñoz J. E., Hieronymus C., Sauerbruch T., Malfertheiner P. Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol. 1995 Oct;90(10):1834–1837. [PubMed] [Google Scholar]
- Lankisch P. G., Andrén-Sandberg A. Standards for the diagnosis of chronic pancreatitis and for the evaluation of treatment. Int J Pancreatol. 1993 Dec;14(3):205–212. doi: 10.1007/BF02784928. [DOI] [PubMed] [Google Scholar]
- Lankisch P. G., Brauneis J., Otto J., Göke B. Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency? Gastroenterology. 1986 Feb;90(2):350–354. [PubMed] [Google Scholar]
- Lankisch P. G., Dröge M., Hofses S., König H., Lembcke B. Steatorrhoea: you cannot trust your eyes when it comes to diagnosis. Lancet. 1996 Jun 8;347(9015):1620–1621. [PubMed] [Google Scholar]
- Lankisch P. G. Exocrine pancreatic function tests. Gut. 1982 Sep;23(9):777–798. doi: 10.1136/gut.23.9.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lankisch P. G., Schreiber A., Otto J. Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Dig Dis Sci. 1983 Jun;28(6):490–493. doi: 10.1007/BF01308149. [DOI] [PubMed] [Google Scholar]
- Löser C., Möllgaard A., Fölsch U. R. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut. 1996 Oct;39(4):580–586. doi: 10.1136/gut.39.4.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sarner M., Cotton P. B. Classification of pancreatitis. Gut. 1984 Jul;25(7):756–759. doi: 10.1136/gut.25.7.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sarner M., Cotton P. B. Definitions of acute and chronic pancreatitis. Clin Gastroenterol. 1984 Sep;13(3):865–870. [PubMed] [Google Scholar]
- Stein J., Jung M., Sziegoleit A., Zeuzem S., Caspary W. F., Lembcke B. Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem. 1996 Feb;42(2):222–226. [PubMed] [Google Scholar]
- Sziegoleit A., Krause E., Klör H. U., Kanacher L., Linder D. Elastase 1 and chymotrypsin B in pancreatic juice and feces. Clin Biochem. 1989 Apr;22(2):85–89. doi: 10.1016/s0009-9120(89)80003-7. [DOI] [PubMed] [Google Scholar]
- Sziegoleit A., Linder D. Studies on the sterol-binding capacity of human pancreatic elastase 1. Gastroenterology. 1991 Mar;100(3):768–774. doi: 10.1016/0016-5085(91)80024-4. [DOI] [PubMed] [Google Scholar]